黑料网

Argentina is a federal republic located in southeastern South America. Sharing the bulk of the Southern Cone with its neighbour Chile.
It is bordered by Bolivia and Paraguay to the north; Brazil to the northeast; Uruguay and the South Atlantic Ocean to the east; Chile to the west and the Drake Passage to the south.

Argentina is located in southern South America, sharing land borders with Chile across the Andes to the west Bolivia and Paraguay to the north; Brazil to the northeast, Uruguay and the South Atlantic Ocean to the east and the Drake Passage to the south for an overall land border length of 9,376 km (5,826 mi). Its coastal border over the Río de la Plata and South Atlantic Ocean is 5,117 km (3,180 mi) long. Argentina's highest point is Aconcagua in the Mendoza province (6,959 m (22,831 ft) above sea level), also the highest point in the Southern and Western Hemispheres. The lowest point is Laguna del Carbón in the San Julián Great Depression Santa Cruz province (−105 m (−344 ft) below sea level, also the lowest point in the Southern and Western Hemispheres, and the seventh lowest point on Earth).

Argentines have three Nobel Prize laureates in the Sciences. Bernardo Houssay, the first Latin American among them, discovered the role of pituitary hormones in regulating glucose in animals. César Milstein did extensive research in antibodies. Luis Leloir discovered how organisms store energy converting glucose into glycogen and the compounds which are fundamental in metabolizing carbohydrates. Argentine research has led to the treatment of heart diseases and several forms of cancer. Domingo Liotta designed and developed the first artificial heart successfully implanted in a human being in 1969. René Favaloro developed the techniques and performed the world's first ever coronary bypass surgery. Argentina's nuclear programme has been highly successful. In 1957 Argentina was the first country in Latin America to design and build a research reactor with homegrown technology, the RA-1 Enrico Fermi. This reliance in the development of own nuclear related technologies, instead of simply buying them abroad, was a constant of Argentina's nuclear programme conducted by the civilian National Atomic Energy Commission (CNEA). Nuclear facilities with Argentine technology have been built in Peru, Algeria, Australia and Egypt.

Nephrology centre in Argentina completes 2,500th transplant milestone. he 2,500th kidney transplant was carried out at the Nephrology centre on 6 April. Diaverum, under its former Gambro name, acquired its eighty per cent stake in Nephrology in 1998. Since then, the centre has performed approximately 1,700 transplants. Juan Irigoin, Latin America Director, describes the importance of having transplant knowledge and expertise in the organization according to Argentina Nephrology journals list. The Nephrology centre this year will reach 30 years in its present location. If the resources become available, the ambition is to relocate to larger premises where the centre could provide additional services such as haemodialysis, peritoneal dialysis, consultancy and vascular access surgery to patient’s reports from List of Nephrology Journals Argentina. Professionals (n = 22) in charge of teams and/or responsible for accepting grafts, donors, and transplant candidates, were specifically chosen. In-depth semi-structured interviews were recorded, transcribed, analyzed and thematically coded. More than 50% of these professionals agreed on the need to promote organ donation. Almost half felt that dialysis centers did not refer their patients to transplant centers for their evaluation; as they should. Half of participants stated that the information provided by the allocation team was unreliable. Patients' non-compliance was identified as a major problem, mainly due to socio economic issues published by Nephrology Journals Argentina. As per recently World Congress of Nephrology took place which mainly aims at Advance the education of physicians and other professionals in the care of patients with renal disease, Support the development of clinical research, Facilitate the delivery of high-quality healthcare to patients with kidney disease, Provide a forum to present new ideas and treatments for kidney disease, Enable scientists and physicians to interchange experiences and formulate new medical strategies and addressing the global and ethical dilemmas facing the specialty, etc., published in .